0.239
0.00 (-0.37%)
| Penutupan Terdahulu | 0.240 |
| Buka | 0.220 |
| Jumlah Dagangan | 410,924 |
| Purata Dagangan (3B) | 933,321 |
| Modal Pasaran | 33,196,644 |
| Harga / Pendapatan (P/E Ke hadapan) | 7.89 |
| Harga / Jualan (P/S) | 0.060 |
| Harga / Buku (P/B) | 0.110 |
| Julat 52 Minggu |
| Margin Keuntungan | -24.95% |
| Margin Operasi (TTM) | -17.76% |
| EPS Cair (TTM) | -0.960 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -34.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 153.47% |
| Nisbah Semasa (MRQ) | 1.05 |
| Aliran Tunai Operasi (OCF TTM) | -6.42 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.88 M |
| Pulangan Atas Aset (ROA TTM) | -36.73% |
| Pulangan Atas Ekuiti (ROE TTM) | -336.65% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Flora Growth Corp. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Purata | 0.50 |
|
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 12.70% |
| % Dimiliki oleh Institusi | 3.96% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |